Literature DB >> 24356729

Are healthcare workers immune to rubella?

Eva Borràs1, Magda Campins2, María Esteve3, Luis Urbiztondo4, Sonia Broner5, José María Bayas6, Josep Costa6, Angela Domínguez7.   

Abstract

Healthcare workers (HCW) have high exposure to infectious diseases, some of which, such as rubella, are vaccine-preventable. The aim of this study was to determine the immunity of HCW against rubella. We performed a seroprevalence study using a self-administered survey and obtained blood samples to determine rubella Immunoglobulin G (IgG) antibody levels in HCW during preventive examinations by five Primary Care Basic Prevention Units and six tertiary hospitals in Catalonia. Informed consent was obtained. IgG was determined using an antibody capture microparticle direct chemiluminometric technique. The odss ratio (OR) and 95% confidence intervals (CI) were calculated. Logistic regression was made to calculate adjusted OR. Of 642 HCW who participated (29.9% physician, 38.8% nurses, 13.3% other health workers and 18% non-health workers), 46.6% were primary care workers and 53.4% hospital workers. Of total, 97.2% had rubella antibodies. HCW aged 30-44 years had a higher prevalence of antibodies (98.4%) compared with HCW aged<30 years (adjusted OR 3.92; 95% CI 1.04-14.85). The prevalence was higher in nurses than in other HCW (adjusted OR: 5.57, 95% CI 1.21-25.59). Antibody prevalence did not differ between females and males (97.4% vs. 97.1%, P 0.89), type of center (97.7% vs. 96.8%, P 0.51) or according to history of vaccination (97.3% vs. 96.8%, P 0.82). Seroprevalence of rubella antibodies is high in HCW, but workers aged<30 years have a higher susceptibility (5.5%). Vaccination should be reinforced in HCW in this age group, due to the risk of nosocomial transmission and congenital rubella.

Entities:  

Keywords:  MMR vaccination; healthcare workers; nosocomial transmission; rubella; seroprevalence

Mesh:

Substances:

Year:  2013        PMID: 24356729      PMCID: PMC4130266          DOI: 10.4161/hv.27498

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  30 in total

1.  Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study.

Authors:  A Domínguez; P Plans; J Costa; N Torner; N Cardenosa; J Batalla; A Plasencia; L Salleras
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-05       Impact factor: 3.267

2.  Results of the rubella elimination program in Catalonia (Spain), 2002-2011.

Authors:  Irene Barrabeig; Nuria Torner; Ana Martínez; Gloria Carmona; Pilar Ciruela; Joan Batalla; Josep Costa; Sergi Hernández; Luis Salleras; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-08       Impact factor: 3.452

Review 3.  Rubella immunity. Defining the level of protective antibody.

Authors:  L P Skendzel
Journal:  Am J Clin Pathol       Date:  1996-08       Impact factor: 2.493

4.  [An outbreak of rubella among hospital personnel and measures taken against hospital infection--cost-benefits of the measure].

Authors:  Yasuhito Nerome; Junichiro Nishi; Rika Fujiyama; Syuji Takei; Masao Yoshinaga; Yoshihumi Kawano
Journal:  Kansenshogaku Zasshi       Date:  2004-11

5.  Consequences of confirmed maternal rubella at successive stages of pregnancy.

Authors:  E Miller; J E Cradock-Watson; T M Pollock
Journal:  Lancet       Date:  1982-10-09       Impact factor: 79.321

6.  New features of rubella in Spain: the evidence of an outbreak.

Authors:  C Lemos; R Ramirez; M Ordobas; D H Guibert; J C Sanz; L Garcia; J F Martinez Navarro
Journal:  Euro Surveill       Date:  2004-04

7.  An outbreak of rubella among hospital personnel.

Authors:  B F Polk; J A White; P C DeGirolami; J F Modlin
Journal:  N Engl J Med       Date:  1980-09-04       Impact factor: 91.245

Review 8.  Economic analyses of rubella and rubella vaccines: a global review.

Authors:  Alan R Hinman; Beryl Irons; Merle Lewis; Kami Kandola
Journal:  Bull World Health Organ       Date:  2002       Impact factor: 9.408

9.  Nosocomial rubella--consequences of an outbreak and efficacy of a mandatory immunization program.

Authors:  P N Heseltine; M Ripper; P Wohlford
Journal:  Infect Control       Date:  1985-09

10.  Fetal infection resulting from maternal rubella after the first trimester of pregnancy.

Authors:  J E Cradock-Watson; M K Ridehalgh; M J Anderson; J R Pattison; H O Kangro
Journal:  J Hyg (Lond)       Date:  1980-12
View more
  5 in total

Review 1.  Vaccination of healthcare workers: A review.

Authors:  Skerdi Haviari; Thomas Bénet; Mitra Saadatian-Elahi; Philippe André; Pierre Loulergue; Philippe Vanhems
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Seroprevalence and durability of rubella virus antibodies in a highly immunized population.

Authors:  Stephen N Crooke; Iana H Haralambieva; Diane E Grill; Inna G Ovsyannikova; Richard B Kennedy; Gregory A Poland
Journal:  Vaccine       Date:  2019-05-21       Impact factor: 3.641

3.  Seroprevalence of antibodies against varicella zoster virus and rubella virus among newly recruited expatriate healthcare workers: a cross-sectional study.

Authors:  Ibrahim Shady
Journal:  BMJ Open       Date:  2018-03-22       Impact factor: 2.692

4.  Prevalence and management of rubella susceptibility in healthcare workers in Italy: A systematic review and meta-analysis.

Authors:  Francesco Paolo Bianchi; Pasquale Stefanizzi; Giusy Diella; Andrea Martinelli; Antonio Di Lorenzo; Maria Serena Gallone; Silvio Tafuri
Journal:  Vaccine X       Date:  2022-08-07

5.  Attitudinal variables and a possible mediating mechanism for vaccination practice in health care workers of a local hospital in L'Aquila (Italy).

Authors:  Maria Scatigna; Leila Fabiani; Giovanna Micolucci; Flavio Santilli; Pasquale Mormile; Anna Rita Giuliani
Journal:  Hum Vaccin Immunother       Date:  2016-09-13       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.